Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 20, 2007
Optimizing aerosol gene delivery and expression in the ovine lung
Gerry McLachlan, Alison Baker, Peter Tennant, et al.
The European Respiratory Journal
|
August 22, 2024
Pharmacological and pre-clinical safety profile of rSIV.F/HN, a hybrid lentiviral vector for cystic fibrosis gene therapy
Alena Moiseenko, Anthony Sinadinos, Ana Sergijenko, et al.
Molecular and Cellular Probes
|
July 21, 2009
An immunocytochemical assay to detect human CFTR expression following gene transfer
Heather Davidson, Abigail Wilson, Robert D Gray, et al.
Nature Biotechnology
|
April 29, 2008
CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression
Stephen C Hyde, Ian A Pringle, Syahril Abdullah, et al.
Biomaterials
|
October 5, 2013
The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep
Eric W F W Alton, Alison Baker, Eilidh Baker, et al.
Thorax
|
February 12, 2013
Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation
Alex R Horsley, Jane C Davies, Robert D Gray, et al.
American Journal of Respiratory Cell and Molecular Biology
|
August 4, 2009
Limitations of the murine nose in the development of nonviral airway gene transfer
Uta Griesenbach, Stephanie G Sumner-Jones, Emma Holder, et al.
Thorax
|
November 18, 2016
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis
Eric W F W Alton, Jeffery M Beekman, A Christopher Boyd, et al.
The Lancet. Respiratory Medicine
|
July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
Eric W F W Alton, David K Armstrong, Deborah Ashby, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 20, 2007
Optimizing aerosol gene delivery and expression in the ovine lung
Gerry McLachlan, Alison Baker, Peter Tennant, et al.
The European Respiratory Journal
|
August 22, 2024
Pharmacological and pre-clinical safety profile of rSIV.F/HN, a hybrid lentiviral vector for cystic fibrosis gene therapy
Alena Moiseenko, Anthony Sinadinos, Ana Sergijenko, et al.
Molecular and Cellular Probes
|
July 21, 2009
An immunocytochemical assay to detect human CFTR expression following gene transfer
Heather Davidson, Abigail Wilson, Robert D Gray, et al.
Nature Biotechnology
|
April 29, 2008
CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression
Stephen C Hyde, Ian A Pringle, Syahril Abdullah, et al.
Biomaterials
|
October 5, 2013
The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep
Eric W F W Alton, Alison Baker, Eilidh Baker, et al.
Thorax
|
February 12, 2013
Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation
Alex R Horsley, Jane C Davies, Robert D Gray, et al.
American Journal of Respiratory Cell and Molecular Biology
|
August 4, 2009
Limitations of the murine nose in the development of nonviral airway gene transfer
Uta Griesenbach, Stephanie G Sumner-Jones, Emma Holder, et al.
Thorax
|
November 18, 2016
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis
Eric W F W Alton, Jeffery M Beekman, A Christopher Boyd, et al.
The Lancet. Respiratory Medicine
|
July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
Eric W F W Alton, David K Armstrong, Deborah Ashby, et al.
Page
of 4